Intraperitoneal perfusion therapy targeting the GDF15-POSTN axis may reduce intraperitoneal metastasis and the formation of ascites in patients with colon cancer, but this approach needs to be further validated in vivo and in clinical trials. Here, GDF15 is linked to colonic neoplasm.